December 5-8, 2020; Online at https://www.hematology.org/meetings/annual-meeting
Initial results from this ongoing phase I study suggest that once-weekly administration of AMG 701 yields encouraging activity with the possibility for deep, durable responses, along with a manageable safety profile.